Status:
COMPLETED
Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV
Eligibility:
All Genders
18+ years
Brief Summary
This study will evaluate a system for predicting the effectiveness of antiretroviral treatment in African HIV clinics where standard testing methods for measuring viral load, such as RNA polymerase ch...
Detailed Description
Routine virological monitoring of HIV-infected patients on antiretroviral therapy (ART) is not currently affordable or available in most African HIV clinics using standard methods such as RNA polymera...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Willing to provide individual informed consent.
- HIV positive. (HIV status will have been confirmed by recognised external testing centre (eg AIC) or if necessary by the IDI lab using Abbott Determine HIV1-2 plus STAT-PAK (Chembio Diagnostic Systems) rapid tests. Unigold (Trinity Biotech) is available for 'tie-breaker' testing if necessary.
- Currently being followed at the Adult Infectious Disease Clinic.
- Patients who are aged 18 years or more.
- Patients on ART for more than 6 months who are PI naive.
- EXCLUSION CRITERIA:
- Inability or unwillingness to provide individual informed consent.
- Patients currently admitted to 'Urgent Care' facility.
- Age less than 18 years.
- Patients enrolled in either 'Clinic' or 'Gates 5B' cohorts.
Exclusion
Key Trial Info
Start Date :
February 16 2006
Trial Type :
OBSERVATIONAL
End Date :
November 15 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00341393
Start Date
February 16 2006
End Date
November 15 2007
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Infectious Disease Institute of Makerere University
Kampala, Uganda